Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Therapeutic Hypothermia After Cardiac Arrest with Non-Shockable Rhythm (HYPERION) Shows Statistically Significant Results In Cardiac Arrest Patients Presented At AHA

The HYPERION study was published in New England Journal of Medicine (NEJM) on October 5, 2019, with a first simultaneous presentation at the ESICM meeting in Berlin, Germany. The study was also presented and discussed at the ReSS meeting, part of the American Heart meeting in Philadelphia on Nov 16, 2019 as a special presentation by the Principal Investigator (PI) of the trial, Dr. Jean-Baptiste Lascarrou. Although, BrainCool was not part of the study, the results will have a large impact on the development of the temperature management market. In 2013, Targeted Temperature Management (

Brighter accelerates the commercialization of Actiste and carries out a rights issue – without trading of subscription rights – of approximately SEK 192 million

The Board of Directors of Brighter AB (publ) ("Brighter" or "the Company") today, with the support of the issuance authorization granted at the Annual General Meeting on May 9, 2019, has decided to carry out a new issue of approximately SEK 192 million ("the Offer") to the Company's shareholders. The terms and conditions have been designed to benefit and reward the Company's shareholders. The Offer does not constitute a customary rights issue, and applies only to those who hold shares in the Company as of the record date of December 12, 2019. Subscription without the support of

Interim Report - January – September, 2019 Redsense Medical AB (publ)

Quarter 3, 2019, showed an increase in sales of 103% versus same period last year and is the strongest in the company’s history. The growth is driven by the US market.Financial Summary Third quarter, 1 July – 30 September 2019 Redsense Medical group · Sales amounted to 4 645 KSEK (2 286), with an increase of 103% compared to 2018. · Earnings before interest and taxes amounted to -590 KSEK (-970). Redsense Medical AB · Net sales amounted to 3 257 KSEK (1 871). · Earnings before interest and taxes amounted to -895 KSEK (-530). 1 January – 30 September 2019

Autoliv Introduces Airbag that Prevents Passengers from Colliding

(Ogden, Utah USA, November 18, 2019) – Autoliv Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in vehicle safety systems, today announced the development of a new front center airbag that is designed to save lives in side-impact crash situations. The airbag will be showcased at Autoliv’s Capital Markets Day held on November 19 at its technical center in Ogden, Utah. The head is one of the most frequently injured body regions in any road collision potentially resulting in devastating long-term consequences for the victim. For side collisions from the opposite side, the

BrainCool AB's (publ) rights issue oversubscribed

The subscription period in BrainCool's rights issue of a maximum of SEK 40.1 million ended on November 13. A total of SEK 42 million was subscribed, a subscription rate of 105%, of which 80% was subscribed with preferential rights. Consequently, no guarantee commitments were needed. BrainCool is allocated SEK 40.1 million before costs associated with the rights issue. CEO Martin Waleij comments; -        I would like to thank existing as well as new shareholders. With the proceeds from this rights issue, we are now continuing our marketing efforts in brain cooling in Germany and the

The use of antimicrobials in food-producing animals is decreasing, but additional investments are needed in the control of antimicrobial resistance

The joint FINRES-Vet 2018 report published by the Finnish Food Authority, the Finnish Medicines Agency Fimea and the University of Helsinki shows that the sales of antimicrobials used in food-producing animals has reduced in Finland in recent years. The antimicrobial resistance situation among bacteria causing disease in animals only or causing disease in both animals and humans has remained relatively good. On the other hand, observations have also been made on increased resistance to antimicrobials.The sales of antimicrobials intended for food-producing animals decreased by 18 per cent

Northmill hires new Chief Analytics and Credit Officer

- Georges Mansourati from Swedbank will be a key player in the fast-growing Swedish tech bank’s continued growthStockholm 18 November 2019: Northmill that recently received a Swedish license to conduct banking operations  continues to attract key competence and is hiring Georges Mansourati as the new Chief Analytics and Credit Officer. Georges has held several leading roles during his eleven years at Swedbank, such as risk analyst, trader, business owner for advanced analytics and as head

PolarCool AB (publ) signs an agreement with Zurich SC Lions in the Swiss hockey league

PolarCool AB (publ) has signed a cooperation agreement with Zurich SC Lions in the Swiss ice hockey league National League A, which is the top tier in the Swiss league system. Zurich SC Lions will evaluate PolarCap® System until the end of the current season.  Zürich SC Lions will thus become a reference team in the Swiss league, in a market where PolarCool (publ) also has good hopes of developing the business.  PolarCool's Erik Andersson comments;  - The fact that Dr. Gery Büsser, a very reputable doctor in this area, now chooses to include the use of PolarCap® System in his

InDex Pharmaceuticals presents at Redeye Life Science Day and Avanza Börsdag November 19, 2019

November 18, 2019 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at ROOTS@Downtown Camper by Scandic, Drottninggatan 28 in Stockholm at 08:35 CET and at Avanza Börsdag at Operaterrassen, Karl XII:s torg in Stockholm at 11:15 CET on November 19. Both presentations will be livestreamed.The presentation at Redeye Life Science Day can be followed at https://www.redeye.se/live/ls-day-2019 and will also be available afterwards on https://www.redeye.se/live/ls-day-2019 and on the company’s page in Redeye

Eurobattery Minerals announces update on Swedish explorations for battery minerals

Eurobattery Minerals AB (NGM; “BAT”), a growth company in the mining and exploration industry with the vision to help Europe become self-sufficient in ethical battery minerals, today announced an update on its explorations projects in Sweden. Similar to the project the company runs in Castriz in northern Spain where the results from the drilling campaign will be announced later in Q4, the focus for the Swedish projects is nickel, cobalt and copper, including also rare earth elements (REE), minerals that are all critical raw materials for the electric vehicle market in Europe. – I am

Redwood Pharma to present at BioStock Live in Stockholm on December 3, 2019

On December 3, CEO Martin Vidaeus from Redwood Pharma will present at BioStock Live (www.biostock.se) in Stockholm. The presentation will be in English. The program and registration for the event can be found on the event’s website, where a link to the live streamed broadcast of the presentation will also be available on December 3. Click on the following link to register: https://www.eventbrite.com/e/biostock-live-sthlm-december-3-biljetter-82498173257?aff=erelexpmlt About RP101RP101 is the company’s lead program for the development of a novel treatment of chronic dry eye disease

Stora Enso launches a new concept for constructing office buildings from wood

STORA ENSO OYJ PRESS RELEASE 18 November 2019 at 09:00 EETStora Enso is launching a new building concept that makes it easier for architects, engineers and developers to design office buildings from wood. The concept provides guidance on the use of prefabricated wooden building components. It also provides information to support the decision-making process for all major stakeholders involved in an office building project. Construction materials account for 40% of all materials used in the world today and 11% of global CO2 emissions. Wood components and building concepts are sustainable

Bittium Exhibits Its Innovative High-Tech Products and Solutions for Cardiology and Neurology at Medica 2019

Press Release Free for release on November 18, 2019 at 09:00 am (CET +1) Bittium Exhibits Its Innovative High-Tech Products and Solutions for Cardiology and Neurology at Medica 2019 Oulu, Finland, November 18, 2019 – Bittium exhibits its innovative products and solutions for cardiology and neurology at Medica 2019, the leading international trade fair for the medical sector, on November 18-21 in Dusseldorf, Germany. Bittium’s next generation’s high-tech solutions for cardiac and brain monitoring enable early detection of abnormalities in electrical activities, and thus speeding up

Photocure: First trial demonstrating reduced recurrence after flexible Blue Light Cystoscopy with Hexvix[®] in surveillance

Use of flexible Blue Light Cystoscopy at the first follow-up after TURBT* reduced the risk of tumor recurrence by 33% compared to white light alone. Randomized controlled multi-center study with 699 bladder cancer patients presented at Danish Urological Society meeting.Oslo, Norway November 18, 2019, Photocure ASA (PHO:OSE), is pleased to announce that results from new studies with flexible Blue Light Cystoscopy (BLC™) with Hexvix were presented at the annual meeting of the Danish Urology Society on Saturday, November 16. Results from a randomized controlled study in 699 patients from

Recipharm to communicate new financial targets on Capital Markets Day

Recipharm AB (publ) has continued to grow and will present its strategy for profitable growth moving forward, together with new financial targets from 2020, at today’s Capital Markets Day in Stockholm. The new financial targets are: · Recipharm’s target is to achieve a Compound Annual Growth Rate (CAGR) of at least 11%, with 2019 as base year. The growth will be organic as well as come from acquisitions.  · Recipharm’s target is to achieve an EBITA margin of at least 12% each year, measured as profit before financial items, tax and amortisation of intangible assets attributable

Newbie continues to conquer Great Britain – new store at Gatwick Airport

Newbie, KappAhl's lifestyle concept in more sustainable materials for babies and children, continues to conquer Great Britain. Newbies first airport store has now opened at Gatwick outside London. Sales started immediately and customer feedback was that they love Newbie!- Building a store on these conditions has been an exciting challenge for our fantastic team: the store is only 25 square meters in size, round to the shape and has no walls - but wow how well we made it and the location is prime! says Camilla Wernlund, international expansion manager for Newbie. Newbie Store has opened

Share buy-backs in Telia Company during week 46 2019

During the period November 11, 2019, until November 15, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,696,184 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back program that Telia Company announced on April 16, 2019. The share buy-back program, which runs between April 16, 2019, and February 28, 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

Ambea announces repurchase of own shares

The Board of Ambea AB (publ) has resolved to initiate a share buyback program for a total of 68,285 shares until May 14, 2020.Repurchased shares will be saved to be used under Ambea’s share savings plan. The buyback program will be managed by a securities company or credit institution that makes its trading decisions regarding Ambea’s shares independently of, and without influence by, Ambea with regard to the timing of the repurchases. The buyback program shall meet the following terms: 1. Repurchases of shares are to be made on Nasdaq Stockholm and in accordance with Nasdaq Stockholm’

Interim report January – September 2019

Catena Media plc (Nasdaq Stockholm: CTM)July - September 2019 (compared with July - September 2018) · Revenues decreased by 5 percent and totalled EUR 26.4m (27.7) · EBITDA decreased by 15 percent and totalled EUR 11.4m (13.4), corresponding to an EBITDA margin of 43 percent (48) · Adjusted EBITDA excluding non-recurring costs decreased by 15 percent and totalled EUR 11.5m (13.6),corresponding to an adjusted EBITDA margin of 44 percent (49) · Net cash generated from operating activities amounted to EUR 9.1m (10.2) · New Depositing Customers (NDCs) totalled 99,435 (138,194),

Selvaag Bolig ASA: Selvaag Bolig aims to refine its housing development business and pay an extraordinary dividend exceeding NOK 2 billion

Selvaag Bolig will propose to the general meeting that it sells large parts of its land bank to Urban Property. These companies will become long-term and strategic partners, and Selvaag Bolig will have a pre-emptive right and option to buy back the land. This transaction is worth NOK 3.4 billion and about NOK 2 billion will be paid as an extraordinary dividend, corresponding to NOK 22.00 per share.     Selvaag Bolig chair Olav H Selvaag says that the transaction will make it possible to refine the company’s core business and make the value of its assets visible. “Selvaag Bolig is a

Selvaag Bolig ASA: Notice of extraordinary general meeting

An extraordinary general meeting of Selvaag Bolig ASA will be held on 9 December 2019 at 10:00 (CET) at Silurveien 2, 0311 Oslo, Norway. Further information fromKristoffer Gregersen, Vice president communications and market Selvaag Bolig ASATelephone: +47 957 75 593, e-mail: kgr@selvaagbolig.no Selvaag Bolig ASA is a residential property developer controlling the entire value chain from acquisition of land to sale of homes. The company has several thousand homes under development at any given time, and focuses on the growth areas in and around Greater Oslo, Bergen, Stavanger and

Azelio signs MoU for 120 MWe of installations in California

Azelio has signed a Memorandum of Understanding (MoU) with the US company BIODICO INC (Biodico) for a project in Atascadero, California. The MoU frameworks a collaboration over a capacity of about 120 MWe of Azelio’s energy storage technology in the US market until 2024. This capacity is distributed along the following timeline: 13 kWe in 2021 (Atascadero project), 15 MWe in 2022, 35 MWe in 2023 and 70 MWe in 2024. Fully installed, the capacity corresponds to approximately 9,000 units of Azelio’s system.The initial project is expected to become operational in 2021, as a commercial

Väderstad named Employer Branding Company of the Year

The awards are coming thick and fast for agricultural machinery manufacturer Väderstad at the moment. Last week they received the ‘Machine of the Year’ award at the world’s largest agricultural exhibition. Now they have also been named ‘Employer Branding Company of the Year’ by research company Universum. At the same time, they also received the ‘Career Company of the Year 2020’ seal of approval and climbed to the top 15 in a national poll of ‘Sweden’s best employers’.Things are going well for the family owned company Väderstad, a global leader in tillage and drilling with over 1,500

There are no items matching the current filter
There are no more items matching the current filter
Back to top